FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.05-5517fje.
This Article
Right arrow Summary
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.05-5517fjev1
20/8/1266    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petermann, I.
Right arrow Articles by Reinheckel, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petermann, I.
Right arrow Articles by Reinheckel, T.
(The FASEB Journal. 2006;20:1266-1268.)
© 2006 FASEB

Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice

Ivonne Petermann*,1, Christian Mayer*,1, Jörg Stypmann{dagger}, Martin L. Biniossek*, Desmond J. Tobin{ddagger}, Markus A. Engelen{dagger}, Thomas Dandekar§, Tilman Grune||, Lorenz Schild, Christoph Peters*,2 and Thomas Reinheckel*

* Institut für Molekulare Medizin und Zellforschung, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany;

{dagger} Medizinische Klinik und Poliklinik C (Kardiologie und Angiologie), Zentrale Projektgruppe Kleintierdiagnostik des Interdisziplinären Zentrums für Klinische Forschung Münster, Universitätsklinikum Westfälische Wilhelms-Universität Münster, Münster, Germany;

{ddagger} Medical Biosciences, School of Life Sciences, University of Bradford, Bradford, West Yorkshire, UK;

§ Lehrstuhl für Bioinformatik, Biozentrum, Am Hubland, Würzburg, Germany;

|| Research Institute for Environmental Medicine at the Heinrich Heine University Duesseldorf, Molecular Aging Research, Duesseldorf, Germany; and

Institut für Klinische Chemie und Pathologische Biochemie, Bereich Pathologische Biochemie, Medizinische Fakultät der Otto-von-Guericke-Universität Magdeburg, Germany

2Correspondence: Institut für Molekulare Medizin und Zellforschung, Albert-Ludwigs-Universität Freiburg, Freiburg D-79104, Germany. E-mail: christoph.peters{at}mol-med.uni.freiburg-de

ABSTRACT

Although lysosomal proteases are expressed in the heart at considerable levels, their specific functions in this organ remain elusive. Mice deficient for the lysosomal cysteine protease cathepsin L (CTSL) develop a late onset dilated cardiomyopathy (DCM) that is characterized by cardiac chamber dilation, fibrosis, and impaired cardiac contraction at 12 month of age. Investigation of the pathogenic sequence of DCM in ctsl–/– mice revealed numerous dysmorphic lysosome-like structures in heart muscle as early as 3 days after birth, whereas skeletal muscle was not affected. Labeling of the acidic cell compartment of neonatal cardiomyocytes and detection of lysosomal markers after subcellular fractionation confirmed increased lysosome content in CTSL deficient myocardium; however, specific storage materials were not detected. The myocardium of ctsl+/+ and ctsl–/– mice revealed no differences in incidence of cell death, proliferation, and capillary density during DCM progression. However, an observed increase in mRNA expression of natriuretic peptides in young adult mice indicates the activation of the adaptive "fetal" gene program, while proteome analysis revealed decreased levels of the sarcomere-associated proteins {alpha}-tropomyosin, desmin, and calsarcin 1, as well as considerable changes of metabolic enzymes. Bioinformatic pathway analysis suggested a switch to anaerobic catabolism and impairment of mitochondrial respiration. This interpretation was supported by a 50% reduction in resting state oxygen consumption and impaired respiration capacity in ctsl–/– myocardial homogenates. In summary, the data indicate an essential role of CTSL in maintaining the structure of the endosomal/lysosomal compartment in cardiomyocytes. Lysosomal impairment in ctsl–/– hearts results in metabolic and sarcomeric alterations that promote DCM development.—Petermann, I., Mayer, C., Stypmann, J., Biniossek, M. L., Tobin, D. J., Engelen, M. A., Dandekar, T., Grune, T., Schild, L., Peters, C., Reinheckel, T. Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Spira, J. Stypmann, D. J. Tobin, I. Petermann, C. Mayer, S. Hagemann, O. Vasiljeva, T. Gunther, R. Schule, C. Peters, et al.
Cell Type-specific Functions of the Lysosomal Protease Cathepsin L in the Heart
J. Biol. Chem., December 21, 2007; 282(51): 37045 - 37052.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. W. Cheng, K. Obata, M. Kuzuya, H. Izawa, K. Nakamura, E. Asai, T. Nagasaka, M. Saka, T. Kimata, A. Noda, et al.
Elastolytic Cathepsin Induction/Activation System Exists in Myocardium and Is Upregulated in Hypertensive Heart Failure
Hypertension, November 1, 2006; 48(5): 979 - 987.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.